Cellular Senescence as a Pathogenic Hub Driving Mechanistic Networks and Reversal Strategies in Idiopathic Pulmonary Fibrosis
Sakina Ruhi, Adlina Abdullatif, Jegathambigai R. Naidu, Hana Chen et autres
Idiopathic pulmonary fibrosis (IPF) is a progressive, ultimately fatal interstitial lung disease for which current antifibrotic therapy — pirfenidone and nintedanib — can slow but not reverse the underlying scarring process, leaving median survival at only three to five years. Over the …
us, my (code pays fourni par la source)